AKT1 and cancer: Notably, the expression of EREG in stromal cells is upregulated and activates several downstream signaling pathways, including the MAPK AKT/mTOR and JAK/STAT pathways, in cancer cells by paracrine signaling, promoting their malignant phenotype and accelerating the progression of cancer (Wang et al., 2022).